Arie Vangorp

Organon is an independent global healthcare company with a strategy to help improve the health of women throughout their lives. Organon’s diverse portfolio offers more than 70 medicines and products in women’s health and general medicines across a range of therapeutic areas. In addition to Organon’s current products, the company invests in innovative solutions and research to drive future growth prospects in women’s health. Organon is also pursuing opportunities to collaborate with biopharmaceutical partners and innovators looking to commercialise their products by leveraging its scale and agile presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,500 employees. This site serves the Northwest Europe region. --------------------- Adverse events must be reported through Organon Pharmacovigilance. Details of how to report adverse events and who to contact for medical information or quality questions related to our products can be found on the contacts pages of the Organon page for the relevant country: Global locations | Organon Our privacy program is built on a platform of organizational accountability at all levels for privacy, stewardship of the data we use to operate our business, consistent global privacy and data protection practices and standards that uphold high ethical standards across our business practices, and ongoing oversight to ensure that we continue to respond to changes in privacy expectations as technology and our business continue to evolve. Visit our Contact Page for more information about your privacy rights and for country specific information. ​